Glow Lifetech Corp. (GLOW.CN)
Glow Lifetech Corp. operates in the Biotechnology industry of the Healthcare sector, headquartered in Etobicoke, ON, CA. The stock last traded at $0.04, up 0.00% on the session, giving a market capitalisation of $8.7M. Its beta of 1.47 implies it has historically moved more than the broad market.
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Glow Lifetech Corp. is most often compared with the following Healthcare names: